These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 7693465)

  • 21. Immunochemical studies on blood groups. Purification and characterization of radioactive 3H-reduced di- to hexasaccharides produced by alkaline beta-elimination-borohydride 3H reduction of Smith degraded blood group A active glycoproteins.
    Wu AM; Kabat EA; Nilsson B; Zopf DA; Gruezo FG; Liao J
    J Biol Chem; 1984 Jun; 259(11):7178-86. PubMed ID: 6539332
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monoclonal antibody 2B5 defines a truncated O-glycan, GlcNAc beta 1-3Gal beta 1-4GlcNAc beta 1-6 (GalNAc), on mucins from deep gastric and duodenal glands as well as metaplasia and neoplasia of gastric differentiation.
    Hanisch FG; Koldovsky U; Borchard F
    Cancer Res; 1993 Oct; 53(20):4791-6. PubMed ID: 8402663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Species specificity of O-linked carbohydrate chains of the oviducal mucins in amphibians: structural analysis of neutral oligosaccharide alditols released by reductive beta-elimination from the egg-jelly coats of Rana clamitans.
    Delplace F; Maes E; Lemoine J; Strecker G
    Biochem J; 2002 May; 363(Pt 3):457-71. PubMed ID: 11964146
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary structure of neutral oligosaccharides derived from respiratory-mucus glycoproteins of a patient suffering from bronchiectasis, determined by combination of 500-MHz 1H-NMR spectroscopy and quantitative sugar analysis. 1. Structure of 16 oligosaccharides having the Gal beta(1----3)GalNAc-ol core (type 1) or the Gal beta(1----3)[GlcNAc beta(1----6)]GalNac-ol core (type 2).
    Klein A; Lamblin G; Lhermitte M; Roussel P; Breg J; Van Halbeek H; Vliegenthart JF
    Eur J Biochem; 1988 Feb; 171(3):631-42. PubMed ID: 3345749
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carbohydrate structures of bovine submaxillary mucin.
    Tsuji T; Osawa T
    Carbohydr Res; 1986 Aug; 151():391-402. PubMed ID: 3768900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Core-typing of O-linked glycans from human gastric mucins. Lack of evidence for the occurrence of the core sequence Gal1-6GalNAc.
    Hanisch FG; Chai W; Rosankiewicz JR; Lawson AM; Stoll MS; Feizi T
    Eur J Biochem; 1993 Oct; 217(2):645-55. PubMed ID: 7693465
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of methylated O-glycan alditols by reversed-phase NanoLC coupled CAD-ESI mass spectrometry.
    Hanisch FG; Müller S
    Methods Mol Biol; 2009; 534():107-15. PubMed ID: 19277532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unbranched polylactosamino-O-glycans on human skim milk mucins exhibit Gal beta(1-4)GlcNAc beta(1-6) repeating units.
    Hanisch FG; Uhlenbruck G; Peter-Katalinic J; Egge H; Dabrowski U; Dabrowski J
    Symp Soc Exp Biol; 1989; 43():155-62. PubMed ID: 2701475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The biosynthesis of branched O-glycans.
    Schachter H; Brockhausen I
    Symp Soc Exp Biol; 1989; 43():1-26. PubMed ID: 2701469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of protein glycosylation by mass spectrometry.
    Nilsson B
    Mol Biotechnol; 1994 Dec; 2(3):243-80. PubMed ID: 7866880
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current Methods for the Characterization of
    Wilkinson H; Saldova R
    J Proteome Res; 2020 Oct; 19(10):3890-3905. PubMed ID: 32893643
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Linkage Analysis of Oligosaccharides and Polysaccharides: A Tutorial.
    Black I; Heiss C; Carlson RW; Azadi P
    Methods Mol Biol; 2021; 2271():249-271. PubMed ID: 33908013
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.